• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Mechanobiology Assays with Applications in Cardiomyocyte Biology and Cardiotoxicity.力学生物学测定及其在心肌细胞生物学和心肌毒性中的应用。
Adv Healthc Mater. 2020 Apr;9(8):e1901656. doi: 10.1002/adhm.201901656. Epub 2020 Apr 9.
2
Moving beyond the comprehensive in vitro proarrhythmia assay: Use of human-induced pluripotent stem cell-derived cardiomyocytes to assess contractile effects associated with drug-induced structural cardiotoxicity.超越全面的体外致心律失常检测:利用人诱导多能干细胞衍生的心肌细胞评估与药物诱导的结构性心脏毒性相关的收缩作用。
J Appl Toxicol. 2018 Sep;38(9):1166-1176. doi: 10.1002/jat.3611. Epub 2018 Feb 27.
3
Chronic Cardiotoxicity Assays Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs).基于人诱导多能干细胞分化的心肌细胞(hiPSC-CMs)的慢性心脏毒性检测。
Int J Mol Sci. 2022 Mar 16;23(6):3199. doi: 10.3390/ijms23063199.
4
Pluripotent Stem Cell Modeling of Anticancer Therapy-Induced Cardiotoxicity.多能干细胞在抗癌治疗诱导的心脏毒性模型中的应用。
Curr Cardiol Rep. 2020 Jun 19;22(8):56. doi: 10.1007/s11886-020-01325-x.
5
Doxorubicin-induced cardiotoxicity is maturation dependent due to the shift from topoisomerase IIα to IIβ in human stem cell derived cardiomyocytes.多柔比星诱导的心脏毒性与成熟度相关,这是由于人源干细胞来源的心肌细胞中拓扑异构酶 IIα 向 IIβ 的转变所致。
J Cell Mol Med. 2019 Jul;23(7):4627-4639. doi: 10.1111/jcmm.14346. Epub 2019 May 20.
6
Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes.使用人诱导多能干细胞衍生心肌细胞评估化妆品化合物的功能心脏毒性。
Arch Toxicol. 2018 Jan;92(1):371-381. doi: 10.1007/s00204-017-2065-z. Epub 2017 Sep 22.
7
Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity.利用人诱导多能干细胞衍生的心肌细胞文库进行药物筛选,揭示了毒性的疾病特异性模式。
Circulation. 2013 Apr 23;127(16):1677-91. doi: 10.1161/CIRCULATIONAHA.113.001883. Epub 2013 Mar 21.
8
Chronic drug-induced effects on contractile motion properties and cardiac biomarkers in human induced pluripotent stem cell-derived cardiomyocytes.慢性药物对人诱导多能干细胞衍生心肌细胞收缩运动特性和心脏生物标志物的影响。
Br J Pharmacol. 2017 Nov;174(21):3766-3779. doi: 10.1111/bph.13713. Epub 2017 Feb 8.
9
Yohimbine Directly Induces Cardiotoxicity on Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.育亨宾直接诱导人诱导多能干细胞衍生心肌细胞的心脏毒性。
Cardiovasc Toxicol. 2022 Feb;22(2):141-151. doi: 10.1007/s12012-021-09709-3. Epub 2021 Nov 24.
10
Use of human induced pluripotent stem cell-derived cardiomyocytes to assess drug cardiotoxicity.使用人诱导多能干细胞衍生的心肌细胞评估药物心脏毒性。
Nat Protoc. 2018 Dec;13(12):3018-3041. doi: 10.1038/s41596-018-0076-8.

引用本文的文献

1
Cell Architecture and Dynamics of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) on Hydrogels with Spatially Patterned Laminin and N-Cadherin.人诱导多能干细胞衍生心肌细胞(hiPSC-CMs)在具有空间图案化层粘连蛋白和N-钙黏蛋白的水凝胶上的细胞结构与动力学
ACS Appl Mater Interfaces. 2025 Jan 8;17(1):174-186. doi: 10.1021/acsami.4c11934. Epub 2024 Dec 16.
2
Effect of extracellular matrix stiffness on efficacy of Dapagliflozin for diabetic cardiomyopathy.细胞外基质硬度对达格列净治疗糖尿病心肌病疗效的影响。
Cardiovasc Diabetol. 2024 Jul 24;23(1):273. doi: 10.1186/s12933-024-02369-x.
3
Human Stem Cells for Cardiac Disease Modeling and Preclinical and Clinical Applications-Are We on the Road to Success?人类干细胞在心脏疾病建模及临床前和临床应用中的作用——我们是否正在走向成功?
Cells. 2023 Jun 27;12(13):1727. doi: 10.3390/cells12131727.
4
Dynamic mechanobiology of cardiac cells and tissues: Current status and future perspective.心脏细胞与组织的动态力学生物学:现状与未来展望
Biophys Rev (Melville). 2023 Mar;4(1):011314. doi: 10.1063/5.0141269. Epub 2023 Mar 29.
5
Potential cardiotoxicity induced by Euodiae Fructus: and experiments and untargeted metabolomics research.吴茱萸引起的潜在心脏毒性:实验与非靶向代谢组学研究
Front Pharmacol. 2022 Oct 24;13:1028046. doi: 10.3389/fphar.2022.1028046. eCollection 2022.
6
Simultaneous imaging of calcium and contraction in the beating heart of zebrafish larvae.斑马鱼幼鱼心跳过程中钙离子和收缩的同步成像。
Theranostics. 2022 Jan 1;12(3):1012-1029. doi: 10.7150/thno.64734. eCollection 2022.
7
Wafer-Scale Patterning of Protein Templates for Hydrogel Fabrication.用于水凝胶制备的蛋白质模板的晶圆级图案化
Micromachines (Basel). 2021 Nov 12;12(11):1386. doi: 10.3390/mi12111386.
8
Physiologic biomechanics enhance reproducible contractile development in a stem cell derived cardiac muscle platform.生理生物力学增强了干细胞衍生心肌平台中可重复的收缩发育。
Nat Commun. 2021 Oct 25;12(1):6167. doi: 10.1038/s41467-021-26496-1.
9
Plakophilin-2 truncating variants impair cardiac contractility by disrupting sarcomere stability and organization.桥粒斑菲素蛋白-2截短变体通过破坏肌节稳定性和组织结构损害心脏收缩力。
Sci Adv. 2021 Oct 15;7(42):eabh3995. doi: 10.1126/sciadv.abh3995.
10
A novel mechanosensitive channel controls osmoregulation, differentiation, and infectivity in .一种新型的机械敏感性通道控制渗透压调节、分化和感染性。
Elife. 2021 Jul 2;10:e67449. doi: 10.7554/eLife.67449.

本文引用的文献

1
High-throughput microfluidic micropipette aspiration device to probe time-scale dependent nuclear mechanics in intact cells.高通量微流控微吸管抽吸装置,用于探测完整细胞中依赖时间尺度的核力学。
Lab Chip. 2019 Nov 7;19(21):3652-3663. doi: 10.1039/c9lc00444k. Epub 2019 Sep 27.
2
Human Pluripotent Stem Cell-Derived Cardiovascular Cells: From Developmental Biology to Therapeutic Applications.人多能干细胞衍生的心血管细胞:从发育生物学到治疗应用。
Cell Stem Cell. 2019 Sep 5;25(3):311-327. doi: 10.1016/j.stem.2019.07.010.
3
Engineered Cardiac Tissues Generated in the Biowire II: A Platform for Human-Based Drug Discovery.在Biowire II中生成的工程化心脏组织:一个基于人类的药物发现平台。
Toxicol Sci. 2019 Nov 1;172(1):89-97. doi: 10.1093/toxsci/kfz168.
4
β-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity.β-心脏肌球蛋白肥厚型心肌病突变导致隐匿头部释放并增加酶活性。
Nat Commun. 2019 Jun 18;10(1):2685. doi: 10.1038/s41467-019-10555-9.
5
Heart Failure and Cancer: Mechanisms of Old and New Cardiotoxic Drugs in Cancer Patients.心力衰竭与癌症:癌症患者中新型及传统心脏毒性药物的作用机制
Card Fail Rev. 2019 May 24;5(2):112-118. doi: 10.15420/cfr.2018.32.2. eCollection 2019 May.
6
Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors: A Scientific Statement From the American Heart Association.心血管肿瘤康复管理癌症患者和幸存者的心血管结局:美国心脏协会的科学声明。
Circulation. 2019 May 21;139(21):e997-e1012. doi: 10.1161/CIR.0000000000000679.
7
Quo Vadis Trastuzumab?: Navigating Cardiac Safety Risk Estimates With Complex Cancer Treatments.曲妥珠单抗何去何从?:通过复杂癌症治疗评估心脏安全风险
JACC Heart Fail. 2019 Mar;7(3):225-227. doi: 10.1016/j.jchf.2018.10.020.
8
Three perspectives on the molecular basis of hypercontractility caused by hypertrophic cardiomyopathy mutations.三种视角下的肥厚型心肌病突变导致的心肌过度收缩的分子基础。
Pflugers Arch. 2019 May;471(5):701-717. doi: 10.1007/s00424-019-02259-2. Epub 2019 Feb 15.
9
SarcTrack.萨氏追踪技术。
Circ Res. 2019 Apr 12;124(8):1172-1183. doi: 10.1161/CIRCRESAHA.118.314505.
10
Mechanical regulation of gene expression in cardiac myocytes and fibroblasts.心肌细胞和成纤维细胞中基因表达的机械调控。
Nat Rev Cardiol. 2019 Jun;16(6):361-378. doi: 10.1038/s41569-019-0155-8.

力学生物学测定及其在心肌细胞生物学和心肌毒性中的应用。

Mechanobiology Assays with Applications in Cardiomyocyte Biology and Cardiotoxicity.

机构信息

Department of Mechanical Engineering, University of California Santa Barbara, Santa Barbara, CA, 93109, USA.

Biomolecular Science and Engineering Program, University of California Santa Barbara, Santa Barbara, CA, 93109, USA.

出版信息

Adv Healthc Mater. 2020 Apr;9(8):e1901656. doi: 10.1002/adhm.201901656. Epub 2020 Apr 9.

DOI:10.1002/adhm.201901656
PMID:32270928
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7480481/
Abstract

Cardiomyocytes are the motor units that drive the contraction and relaxation of the heart. Traditionally, testing of drugs for cardiotoxic effects has relied on primary cardiomyocytes from animal models and focused on short-term, electrophysiological, and arrhythmogenic effects. However, primary cardiomyocytes present challenges arising from their limited viability in culture, and tissue from animal models suffers from a mismatch in their physiology to that of human heart muscle. Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) can address these challenges. They also offer the potential to study not only electrophysiological effects but also changes in cardiomyocyte contractile and mechanical function in response to cardiotoxic drugs. With growing recognition of the long-term cardiotoxic effects of some drugs on subcellular structure and function, there is increasing interest in using hiPSC-CMs for in vitro cardiotoxicity studies. This review provides a brief overview of techniques that can be used to quantify changes in the active force that cardiomyocytes generate and variations in their inherent stiffness in response to cardiotoxic drugs. It concludes by discussing the application of these tools in understanding how cardiotoxic drugs directly impact the mechanobiology of cardiomyocytes and how cardiomyocytes sense and respond to mechanical load at the cellular level.

摘要

心肌细胞是驱动心脏收缩和舒张的动力单元。传统上,心脏毒性药物的测试依赖于动物模型的原代心肌细胞,并侧重于短期的电生理和致心律失常作用。然而,原代心肌细胞在培养中存在着活力有限的挑战,并且动物模型的组织在生理学上与人类心肌不匹配。人诱导多能干细胞衍生的心肌细胞(hiPSC-CMs)可以解决这些挑战。它们还提供了研究心肌细胞电生理作用以及对心脏毒性药物的收缩和机械功能变化的潜力。随着人们越来越认识到一些药物对亚细胞结构和功能的长期心脏毒性作用,人们越来越有兴趣使用 hiPSC-CMs 进行体外心脏毒性研究。这篇综述简要概述了可用于定量测量心肌细胞产生的主动力变化以及对心脏毒性药物固有硬度变化的技术。最后讨论了这些工具在理解心脏毒性药物如何直接影响心肌细胞的机械生物学以及心肌细胞如何在细胞水平上感知和响应机械负荷方面的应用。